Gene: SLC4A10

57282
NBCn2|NCBE
solute carrier family 4 member 10
protein-coding
2q24.2
Ensembl:ENSG00000144290 MIM:605556 Vega:OTTHUMG00000153938 UniprotKB:Q6U841
NG_021401.1
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.320e-1 (AD)  4.860e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs16846221chr2:161963710 (GRCh38.p7)G>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg16640027chr2:162480963SLC4A10Promoter1.791e-4Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
FRMPD40.979
MYT1L0.977
GABRG20.976
CLVS20.975
OLFM30.973
CREG20.973
FAXC0.971
ADAM220.97
ATRNL10.97
SYNJ10.97

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CSAG1-0.587
HEY2-0.562
RAB13-0.554
RNF135-0.548
MYL3-0.547
COPZ2-0.531
CHST14-0.526
ROM1-0.517
CMTM3-0.516
FLT3LG-0.516

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB01390Sodium bicarbonateSmall Molecule144-55-8ApprovedTransporter
ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
D000082AcetaminophenAcetaminophen results in increased expression of SLC4A10 mRNA22230336
D020106AcrylamideAcrylamide results in decreased expression of SLC4A10 mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of SLC4A10 gene27153756
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of SLC4A10 mRNA21298039
D000643Ammonium ChlorideAmmonium Chloride affects the expression of SLC4A10 mRNA16483693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of SLC4A10 mRNA26001963
C006780bisphenol Abisphenol A affects the expression of SLC4A10 mRNA25181051
C013418bromfenacoumbromfenacoum results in increased expression of SLC4A10 protein28903499
D003042CocaineCocaine results in increased expression of SLC4A10 protein25100957
C546771gardiquimodgardiquimod results in increased expression of SLC4A10 mRNA28003376
C546771gardiquimodProtein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLC4A10 mRNA]28003376
C018091maduramicinmaduramicin results in increased expression of SLC4A10 mRNA29128925
D008345ManganeseManganese results in decreased expression of SLC4A10 mRNA17175027
C025340manganese chloridemanganese chloride results in decreased expression of SLC4A10 mRNA17175027
C016599mono-(2-ethylhexyl)phthalatemono-(2-ethylhexyl)phthalate results in decreased expression of SLC4A10 mRNA22401849
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SLC4A10 mRNA"25510870
D011192Potassium DichromatePotassium Dichromate results in increased expression of SLC4A10 mRNA23608068
D011374ProgesteroneProgesterone results in increased expression of SLC4A10 mRNA19690047
D047428Protein Kinase InhibitorsProtein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLC4A10 mRNA]28003376
D014635Valproic AcidValproic Acid results in decreased methylation of SLC4A10 gene29154799
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of SLC4A10 gene25560391

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005452inorganic anion exchanger activity-TAS-  
GO:0008509anion transmembrane transporter activity-IBA21873635  
GO:0008510sodium:bicarbonate symporter activity-IBA21873635  
GO:0015301anion:anion antiporter activity-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0006814sodium ion transport-IEA-  
GO:0006821chloride transport-NAS10993873  
GO:0009416response to light stimulus-IEA-  
GO:0009791post-embryonic development-IEA-  
GO:0015701bicarbonate transport-IBA21873635  
GO:0015701bicarbonate transport-NAS10993873  
GO:0015701bicarbonate transport-TAS-  
GO:0021860pyramidal neuron development-IEA-  
GO:0035264multicellular organism growth-IEA-  
GO:0035641locomotory exploration behavior-IEA-  
GO:0048854brain morphogenesis-IEA-  
GO:0051453regulation of intracellular pH-IBA21873635  
GO:0098656anion transmembrane transport-IEA-  
GO:1902600proton transmembrane transport-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-IBA21873635  
GO:0016021integral component of membrane-NAS10993873  
GO:0016323basolateral plasma membrane-IEA-  
GO:0043025neuronal cell body-IEA-  
GO:0097440apical dendrite-IEA-  
GO:0097441basal dendrite-IEA-  
GO:0097442CA3 pyramidal cell dendrite-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-382551Transport of small moleculesTAS
R-HSA-425381Bicarbonate transportersTAS
R-HSA-425393Transport of inorganic cations/anions and amino acids/oligopeptidesTAS
R-HSA-425407SLC-mediated transmembrane transportTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal